Cellectar Biosciences, Inc. Liabilities Assumed
Cellectar Biosciences, Inc. (CLRB) reported Liabilities Assumed of $0 for the 12-month period ending 2017-12-31, per its 10-K filed 2018-03-21.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:LiabilitiesAssumed1 · last filed 2018-03-21
- Cellectar Biosciences, Inc. liabilities assumed for the quarter ending 2017-12-31 was $0.00, a 100.00% decline year-over-year.
- Cellectar Biosciences, Inc. liabilities assumed for the quarter ending 2017-09-30 was $0.00.
- Cellectar Biosciences, Inc. liabilities assumed for the quarter ending 2016-12-31 was $429.00.
- Cellectar Biosciences, Inc. liabilities assumed for the quarter ending 2016-09-30 was $0.00.
- Cellectar Biosciences, Inc. liabilities assumed for fiscal 2017 was $0.00, a 100.00% decline from fiscal 2016.
- Cellectar Biosciences, Inc. liabilities assumed for fiscal 2016 was $1.39M.
- Cellectar Biosciences, Inc. liabilities assumed for fiscal 2015 was $0.00.
- Cellectar Biosciences, Inc. liabilities assumed for fiscal 2013 was $0.00.
| Period end | Liabilities Assumed 3 month | Liabilities Assumed 6 month | Liabilities Assumed 9 month | Liabilities Assumed 9 month as first filed | Liabilities Assumed 12 month | Liabilities Assumed 12 month as first filed | Liabilities Assumed 104 month | Liabilities Assumed 107 month | Liabilities Assumed 110 month | Liabilities Assumed 113 month | Liabilities Assumed 116 month | Liabilities Assumed 119 month | Liabilities Assumed 122 month | Liabilities Assumed 125 month | Liabilities Assumed 128 month | Liabilities Assumed 131 month | Liabilities Assumed 134 month | Liabilities Assumed 137 month |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2017-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-21 | $0.00 derived: sum of 2 quarters · filed 2018-03-21 | $0.00 10-K · filed 2018-03-21 | |||||||||||||||
| 2017-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $0.00 10-Q · filed 2017-11-09 | ||||||||||||||||
| 2017-06-30 | $0.00 10-Q · filed 2017-08-14 | |||||||||||||||||
| 2016-12-31 | $429.00 derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-21 | $429.00 derived: sum of 2 quarters · filed 2018-03-21 | $1.39M 10-K · filed 2018-03-21 | |||||||||||||||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $1.39M 10-Q · filed 2017-11-09 | ||||||||||||||||
| 2016-06-30 | $1.39M 10-Q · filed 2017-08-14 | |||||||||||||||||
| 2015-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-15 | $0.00 derived: sum of 2 quarters · filed 2017-03-15 | $0.00 10-K · filed 2017-03-15 | |||||||||||||||
| 2015-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-10 | $0.00 10-Q · filed 2016-11-10 | ||||||||||||||||
| 2015-06-30 | $0.00 10-Q · filed 2016-08-11 | |||||||||||||||||
| 2014-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $439.62K 10-Q · filed 2014-05-14 | |||||||||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-19 | $0.00 derived: sum of 2 quarters · filed 2014-03-19 | $0.00 derived: sum of 3 quarters · filed 2014-03-19 | $0.00 10-K · filed 2014-03-19 | $439.62K 10-K · filed 2014-03-19 | |||||||||||||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $0.00 derived: sum of 2 quarters · filed 2013-11-13 | $0.00 10-Q · filed 2013-11-13 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $439.62K 10-Q · filed 2013-11-13 | |||||||||||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $0.00 10-Q · filed 2013-08-12 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $439.62K 10-Q · filed 2013-08-12 | |||||||||||||
| 2013-03-31 | $0.00 10-Q · filed 2014-05-14 | $0.00 derived: sum of 2 quarters · filed 2014-05-14 | $0.00 derived: sum of 3 quarters · filed 2014-05-14 | $0.00 derived: sum of 4 quarters · filed 2014-05-14 | $439.62K 10-Q · filed 2013-05-15 | |||||||||||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-19 | $0.00 derived: sum of 2 quarters · filed 2014-03-19 | $0.00 derived: sum of 3 quarters · filed 2014-03-19 | $0.00 10-K · filed 2014-03-19 | -$439.62K 10-K · filed 2013-03-28 | |||||||||||||
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-13 | $0.00 derived: sum of 2 quarters · filed 2013-11-13 | $0.00 10-Q · filed 2013-11-13 | $1.00 derived: sum of 4 quarters · filed 2013-11-13 | -$439.62K 10-Q · filed 2012-11-06 | |||||||||||||
| 2012-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-12 | $0.00 10-Q · filed 2013-08-12 | $1.00 derived: sum of 3 quarters · filed 2013-08-12 | $1.00 derived: sum of 4 quarters · filed 2013-08-12 | -$439.62K 10-Q · filed 2012-08-09 | |||||||||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-15 | $1.00 derived: sum of 2 quarters · filed 2013-05-15 | $1.00 derived: sum of 3 quarters · filed 2013-05-15 | $439.62K 10-Q · filed 2012-05-04 | ||||||||||||||
| 2011-12-31 | $1.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-28 | $1.00 derived: sum of 2 quarters · filed 2013-03-28 | -$439.62K 10-K · filed 2013-03-28 | $439.62K 10-K · filed 2012-03-09 | $439.62K 10-K · filed 2012-03-09 | |||||||||||||
| 2011-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-06 | -$439.62K 10-Q · filed 2012-11-06 | $439.62K 10-Q · filed 2011-11-07 | $439.62K 10-Q · filed 2011-11-07 | ||||||||||||||
| 2011-06-30 | -$439.62K 10-Q · filed 2012-08-09 | -$439.62K 10-Q · filed 2011-08-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| ATOSSA THERAPEUTICS, INC. (ATOS) | United States | $0.021B | -0.52 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |
| Lipocine Inc. (LPCN) | United States | $0.017B | -1.79 |
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| PALATIN TECHNOLOGIES INC (PTN) | United States | $0.017B | -5.36 |
| Allarity Therapeutics, Inc. (ALLR) | United States | $0.017B | -1.66 |